PT Millennium Pharmacon International Tbk (SDPC.JK)
IDR 117.0
(-1.68%)
IDR 117.0
(-1.68%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 535.87 Billion IDR | -0.48% |
| 2022 | 538.43 Billion IDR | 18.78% |
| 2021 | 453.3 Billion IDR | 16.43% |
| 2020 | 389.34 Billion IDR | -17.06% |
| 2019 | 469.41 Billion IDR | 2.6% |
| 2018 | 457.5 Billion IDR | 42.4% |
| 2017 | 321.29 Billion IDR | 14.83% |
| 2016 | 279.78 Billion IDR | 12.38% |
| 2015 | 248.97 Billion IDR | 28.96% |
| 2014 | 193.05 Billion IDR | 0.88% |
| 2013 | 191.38 Billion IDR | 36.68% |
| 2012 | 140.02 Billion IDR | 16.73% |
| 2011 | 119.95 Billion IDR | 23.23% |
| 2010 | 97.34 Billion IDR | 1.56% |
| 2009 | 95.85 Billion IDR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 582.59 Billion IDR | -7.0% |
| 2024 Q3 | 557.07 Billion IDR | -4.38% |
| 2024 Q1 | 626.47 Billion IDR | 16.91% |
| 2023 FY | 535.87 Billion IDR | -0.48% |
| 2023 Q3 | 515.26 Billion IDR | -2.34% |
| 2023 Q1 | 528.91 Billion IDR | -1.77% |
| 2023 Q4 | 535.87 Billion IDR | 4.0% |
| 2023 Q2 | 527.58 Billion IDR | -0.25% |
| 2022 Q2 | 459.68 Billion IDR | -1.62% |
| 2022 Q3 | 477.66 Billion IDR | 3.91% |
| 2022 FY | 538.43 Billion IDR | 18.78% |
| 2022 Q4 | 538.43 Billion IDR | 12.72% |
| 2022 Q1 | 467.27 Billion IDR | 3.08% |
| 2021 Q2 | 430.71 Billion IDR | 4.42% |
| 2021 Q1 | 412.46 Billion IDR | 5.94% |
| 2021 FY | 453.3 Billion IDR | 16.43% |
| 2021 Q4 | 453.3 Billion IDR | -16.72% |
| 2021 Q3 | 544.28 Billion IDR | 26.37% |
| 2020 FY | 389.34 Billion IDR | -17.06% |
| 2020 Q2 | 459.04 Billion IDR | 4.32% |
| 2020 Q4 | 389.34 Billion IDR | -4.97% |
| 2020 Q1 | 440.03 Billion IDR | -6.26% |
| 2020 Q3 | 409.71 Billion IDR | -10.75% |
| 2019 Q2 | 455.6 Billion IDR | -5.2% |
| 2019 FY | 469.41 Billion IDR | 2.6% |
| 2019 Q4 | 469.41 Billion IDR | 8.98% |
| 2019 Q1 | 480.6 Billion IDR | 5.05% |
| 2019 Q3 | 430.73 Billion IDR | -5.46% |
| 2018 Q2 | 359.26 Billion IDR | 10.64% |
| 2018 FY | 457.5 Billion IDR | 42.4% |
| 2018 Q4 | 457.5 Billion IDR | 18.03% |
| 2018 Q3 | 387.6 Billion IDR | 7.89% |
| 2018 Q1 | 324.72 Billion IDR | 1.07% |
| 2017 Q2 | 308.35 Billion IDR | 15.63% |
| 2017 Q4 | 321.29 Billion IDR | 1.94% |
| 2017 Q3 | 315.18 Billion IDR | 2.21% |
| 2017 FY | 321.29 Billion IDR | 14.83% |
| 2017 Q1 | 266.67 Billion IDR | -4.69% |
| 2016 Q1 | 224.12 Billion IDR | -9.98% |
| 2016 FY | 279.78 Billion IDR | 12.38% |
| 2016 Q2 | 296.35 Billion IDR | 32.23% |
| 2016 Q3 | 254.87 Billion IDR | -14.0% |
| 2016 Q4 | 279.78 Billion IDR | 9.77% |
| 2015 Q3 | 222.11 Billion IDR | -14.02% |
| 2015 Q1 | 205 Billion IDR | 6.19% |
| 2015 FY | 248.97 Billion IDR | 28.96% |
| 2015 Q4 | 248.97 Billion IDR | 12.09% |
| 2015 Q2 | 258.34 Billion IDR | 26.02% |
| 2014 Q3 | 190.46 Billion IDR | 9.84% |
| 2014 FY | 193.05 Billion IDR | 0.88% |
| 2014 Q4 | 193.05 Billion IDR | 1.36% |
| 2014 Q1 | 162.96 Billion IDR | -14.85% |
| 2014 Q2 | 173.4 Billion IDR | 6.41% |
| 2013 Q4 | 191.38 Billion IDR | 23.07% |
| 2013 Q1 | 131.48 Billion IDR | -6.1% |
| 2013 Q3 | 155.5 Billion IDR | 4.39% |
| 2013 Q2 | 148.97 Billion IDR | 13.3% |
| 2013 FY | 191.38 Billion IDR | 36.68% |
| 2012 Q4 | 140.02 Billion IDR | 6.46% |
| 2012 Q3 | 131.52 Billion IDR | 0.0% |
| 2012 FY | 140.02 Billion IDR | 16.73% |
| 2011 FY | 119.95 Billion IDR | 23.23% |
| 2010 FY | 97.34 Billion IDR | 1.56% |
| 2009 FY | 95.85 Billion IDR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| PT Enseval Putera Megatrading Tbk. | 3843.44 Billion IDR | 86.057% |
| PT Itama Ranoraya Tbk | 133.25 Billion IDR | -302.13% |
| PT Kimia Farma (Persero) Tbk | 2504.06 Billion IDR | 78.6% |
| PT Soho Global Health Tbk | 1390.85 Billion IDR | 61.472% |